-
You can invest up to 10,000 of your 100,000 credits in each question.
-
Now please select the likeliest answer and invest.
- 1,000 credits say "Maybe"
- 5,000 is "Probably"
- 10,000 signal "I am certain".
-
The more you buy, the higher the price. The next trader must pay even more. Go on.
-
Click the green check-mark to execute the trade.
-
Deal? The system confirms if your transaction has been executed.
-
Here you can see how many Credits you have invested so far.
-
You can cash out your Credits at any time with the orange "C"-Button.
-
This is how the question will be judged in the end, when the final outcome becomes known.
-
This is the precise date or end of the period to which the question refers.
-
After reading the judgement rule, please click here.
Price trend
TransactionsNo transaction data yet
-
Study the background information carefully.
-
Read the background information carefully, before proceeding.
Wiki article
EditInfluenza A
Of the four major strains of the influenza virus, A and B cause most human illness and the annual flu epidemics, novel A subtypes can even result in pandemics (e.g. H1N1 for the 1918 flu pandemic) and are responsible for most severe cases and deaths. [1]
The novel vaccine
A new universal vaccine against the influenza A virus was tested successfully on mice and ferrets. It conferred protection against multiple distinct influenza A strains in mice and ferrets. [2]
Phase 1 clinical trial
A Phase 1 clinical trial of a candidate vaccine, BPL-1357 has begun inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Bethesda, Maryland. The placebo-controlled trial will test the safety and its ability to prompt immune responses. [3] It is scheduled to complete on 1 March 2023, and will generate evidence for safety and Immunogenicity against various strains. [4]
Sources
- Types of Influenza Viruses. CDC
- An inactivated multivalent influenza A virus vaccine. Science, 13 July 2022
- Trial of potential universal flu vaccine opens. NIH, 28 June 2022
- Safety and Immunogenicity of BPL-1357. ClinicalTrials.gov, 7 July 2022
-
Offering the reason for your trade may convince other traders to follow your opinion.
-
Click '+' if you agree, or '–' to disagree. You get a credit for every rating you make.
-
For each '+' the author will get +100 credits added to his trading account .
-
If you rate a comment with "-", please reply and state your objection.
-
Now please rate, reply, or write your own comment. Best of luck!